D. Miller

发表

Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders.

N. Andreasen, D. O’Leary, M. Flaum, 1995, Journal of psychiatric research.

Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics.

N C Andreasen, S Arndt, N. Andreasen, 1999, The American journal of psychiatry.

Schizophrenia: Its Etiology and Impact

D. Miller, 1996, Pharmacotherapy.

Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms

N C Andreasen, M Flaum, S Arndt, 1995 .

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

N C Andreasen, M Flaum, N. Andreasen, 2000, The American journal of psychiatry.

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.

R. Cadoret, S. Arndt, D. Miller, 1991, The American journal of psychiatry.

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

Del D. Miller, D. Miller, P. Perry, 1994, The Journal of clinical psychiatry.

A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia.

N. Andreasen, P. Nopoulos, B. Ho, 1999, The Journal of clinical psychiatry.

Treatment of schizophrenia 1999

L. Siever, K. Davis, L. DeLisi, 1999 .

Alogia, attentional impairment, and inappropriate affect: Their status in the dimensions of schizophrenia

N. Andreasen, S. Arndt, Stephan Arndt, 1993, Schizophrenia Research.

Clinical and biochemical correlates of ‘high-dose’ clozapine therapy for treatment — refractory schizophrenia

P. Buckley, D. Miller, L. Friedman, 2001, Schizophrenia Research.

Clozapine-associated neutropenic enterocolitis.

D. Miller, D. A. Beck, 1994, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Effect of phenytoin on plasma clozapine concentrations in two patients.

D. Miller, 1991, The Journal of clinical psychiatry.

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

N. Andreasen, R. Cadoret, D. Miller, 1993, Schizophrenia Research.

Haloperidol dosing requirements: the contribution of smoking and nonlinear pharmacokinetics.

S. Arndt, D. Smith, D. Miller, 1993, Journal of clinical psychopharmacology.

A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.

N. Andreasen, M. Flaum, Stephan Arndt, 1995, Archives of general psychiatry.

Cimetidine-imipramine interaction: a case report.

D. Miller, M. Macklin, 1983, The American journal of psychiatry.

Review and management of clozapine side effects.

Del D. Miller, D. Miller, 2000, The Journal of clinical psychiatry.

When symptoms persist: clozapine augmentation strategies.

J. Csernansky, Del D. Miller, P. Buckley, 2001, Schizophrenia bulletin.

The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography.

Del D. Miller, D. Miller, P. Perry, 1991, Therapeutic drug monitoring.

Serum haloperidol concentrations and clinical response in acute psychosis.

D. Greenblatt, L. Hershey, D. Abernethy, 1984, Journal of clinical psychopharmacology.

Haloperidol plasma levels and dose optimization.

W. Coryell, D. Miller, P. Perry, 1998, The American journal of psychiatry.

Negative symptoms in antipsychotic-naive schizophrenics and the effect of haloperidol

N. Andreasen, Stephan Arndt, D. Miller, 1994, Biological Psychiatry.

Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update.

N. Andreasen, M. Flaum, P. Nopoulos, 1995, Psychopathology.

Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia

W. Coryell, S. Arndt, M. Kelly, 2005, Psychopharmacology.

Diagnosis, methodology and subtypes of schizophrenia.

N. Andreasen, M. Flaum, S. Schultz, 1997, Neuropsychobiology.

Cimetidine's Effect on Steady-State Serum Nortriptyline Concentrations

D. Miller, J. Duffy, J. Sawyer, 1983, Drug intelligence & clinical pharmacy.

A case of clozapine-induced neuroleptic malignant syndrome.

R. Kathol, D. Miller, M. Sharafuddin, 1991, Journal of Clinical Psychiatry.

The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia.

D. Miller, 1996, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.